Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue

By Anouar A.   Clerget M.-S.   Durroux T.   Barberis C.   Germain G.  

European Journal of Pharmacology, Vol. 308, Iss. 1, 1996-07 ,pp. : 87-96

Elsevier

Access to resources Recommend Favorite

Molecular Pharmacology of V 1a Vasopressin Receptors

By Howl J.   Wheatley M.  

General Pharmacology, Vol. 26, Iss. 6, 1995-10 ,pp. : 1143-1152

Elsevier

Access to resources Recommend Favorite

Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V 1 and V 2 receptors and nitric oxide

By Fernandez N.   Garca J.L.   Garca-Villalon A.L.   Monge L.   Gomez B.   Dieguez G.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 225-233

Elsevier

Access to resources Recommend Favorite

Ameliorative effect of vasopressin-(4-9) through vasopressin V 1A receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze

By Mishima K.   Tsukikawa H.   Inada K.   Fujii M.   Iwasaki K.   Matsumoto Y.   Abe K.   Egawa T.   Fujiwara M.  

European Journal of Pharmacology, Vol. 427, Iss. 1, 2001-09 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Properties of a new radioiodinated antagonist for human vasopressin V 2 and V 1a receptors

By Ala Y.   Morin D.   Mahe E.   Cotte N.   Mouillac B.   Jard S.   Barberis C.   Tribollet E.   Dreifuss J.-J.   Sawyer W.H.   Wo N.C.   Chan W.Y.   Kolodziejczyk A.S.   Cheng L.L.   Manning M.  

European Journal of Pharmacology, Vol. 331, Iss. 2, 1997-07 ,pp. : 285-293

Elsevier

Access to resources Recommend Favorite